To Do or Not to Do: Axillary Nodal Evaluation after ACOSOG Z0011 Trial

Authors:

Abstract
The results of the Z0011 trial are practice-changing, and as they are integrated into the surgical algorithms for breast cancer management, breast imagers will need to redefine their role in the preoperative assessment of the axilla and work collaboratively with surgeons, allowing the most appropriate treatment for each patient. Methods of axillary evaluation in invasive breast cancer continue to evolve. The recent American College of Surgeons Oncology Group Z0011 Trial is a prospective, randomized, multicenter trial that compared the survival and locoregional recurrence rates after complete axillary lymph node dissection (ALND) versus sentinel node biopsy (SNB) alone in women with a positive sentinel node in an effort to avoid the complications associated with ALND. As the results of this trial are implemented clinically, affecting surgical management of axillary metastatic disease, radiologists may need to redefine their role in the preoperative assessment of the axilla. Before the Z0011 trial, breast imagers worked to identify axillary metastases preoperatively, allowing appropriate patients to proceed directly to ALND and avoiding the need for SNB. However, the Z0011 trial concluded that ALND may not be necessary in women with metastatic axillary disease who meet the trial criteria. In the Z0011 trial, after 6 years of median...

This publication has 23 references indexed in Scilit: